共 13 条
- [1] Klinkenberg-Knol E.C., Recent advances in the management of gastroesophageal reflux disease, Scand J Gastroenterol, 26, pp. 101-107, (1991)
- [2] Naccarato R., Cremer M., Damman H.G., Keohane P.P., Mulder H., Sarles H., Et al., Nizatidine versus ranitidine in gastric ulcer disease, Scand J Gastroenterol, 22, pp. 71-78, (1987)
- [3] Simon B., Cremer M., Damman H.G., Hentschel E., Mueller P., Sarles H., Et al., 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer: A multicentre study in Europe, Scand J Gastroenterol, 22, pp. 61-70, (1987)
- [4] Koelz H.R., Birchler R., Bretiiolz A., Bros B., Caitraink Y., Delmore G., Healing and relapse of reflux esophagitis during treatment with ranitidine, Gastroenterology, 91, pp. 1198-1205, (1986)
- [5] Lethola J., Niemkla S., Martikainen J., Krekela I., Ranitidine, 150mg three times a day, in the treatment of reflux esophagitis. A placebo-controlled, double blind study, Scand J Gastroenterol, 21, pp. 175-180, (1986)
- [6] Pace F., Sangaletti O., Bianchi Porro G., Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis, Ital J Gastroenterol, 22, pp. 28-32, (1990)
- [7] Berges W., Lux G., Simon B., Wienbeck M., Qrik R., A comparison of two doses of nizatidine in reflux oesophagitis [abstract]. Z, Gastroenterol, 3, (1989)
- [8] Quik R., Cooper M.J., Gleeson M., Hentschel E., Schuetze K.S., Kingston R.D., Et al., A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis, Aliment Pharmacol Therap, 4, pp. 201-211, (1990)
- [9] Cloud M., Offen W.W., Robinson M., Nizatidine versus placebo in gastroesophageal reflux disease: A 12-week, multicenter, randomized, double-blind study, Am J Gastroenterol, 86, pp. 1735-1742, (1991)
- [10] Siegel S., Nonparametric Statistics for the Behavioral Sciences, (1956)